APA (7th ed.) Citation

Garralda, E., Fiedler, W., Matos, I., Rolling, C., Kebenko, M., Klinghammer, K., . . . Zurlo, A. (2019). SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. Annals of Oncology, 30, iv125. https://doi.org/10.1093/annonc/mdz157.009

Chicago Style (17th ed.) Citation

Garralda, E., et al. "SO-010 - Preliminary Results in Colorectal Cancer (CRC) Patients Enrolled in the GATTO Study, a Phase I Study of Tomuzotuximab in Combination with Gatipotuzumab in Patients with EGFR Positive Solid Tumors." Annals of Oncology 30 (2019): iv125. https://doi.org/10.1093/annonc/mdz157.009.

MLA (9th ed.) Citation

Garralda, E., et al. "SO-010 - Preliminary Results in Colorectal Cancer (CRC) Patients Enrolled in the GATTO Study, a Phase I Study of Tomuzotuximab in Combination with Gatipotuzumab in Patients with EGFR Positive Solid Tumors." Annals of Oncology, vol. 30, 2019, p. iv125, https://doi.org/10.1093/annonc/mdz157.009.